Dizal Pharmaceutical

SCMP · Jul 20 at 06:03 PM

‘Systemic leap’: China’s drug innovation push yields bumper crop

CoinLive · Jul 15 at 07:13 AM

Institutional Investors Net Buy Kailan Ying, Giant Network, Aerospace Electronics on July 15

Pharmaceutical Technology · Jul 14 at 09:14 AM

AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug

prnewswire · Jul 14 at 01:01 AM

02:00 ETDizal Announces Global Exclusive License Agreement with AstraZeneca for Zegfrovy

prnewswire · May 30 at 07:10 PM

20:09 ETDizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

prnewswire · May 29 at 07:53 AM

08:52 ETDizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer